AUTHOR=Khedjat Kahina , Lenain Rémi , Hamroun Aghilès , Baes Dulciane , Top Isabelle , Labalette Myriam , Lopez Benjamin , Van Triempont Marine , Provôt François , Frimat Marie , Gibier Jean-Baptiste , Hazzan Marc , Maanaoui Mehdi TITLE=Post-Transplantation Early Blood Transfusion and Kidney Allograft Outcomes: A Single-Center Observational Study JOURNAL=Transplant International VOLUME=35 YEAR=2022 URL=https://www.frontierspartnerships.org/journals/transplant-international/articles/10.3389/ti.2022.10279 DOI=10.3389/ti.2022.10279 ISSN=1432-2277 ABSTRACT=

The association between blood transfusion and the occurrence of de novo HLA donor specific antibodies (DSA) after kidney transplantation remains controversial. In this single-center observational study, we examined the association between early blood transfusion, i.e. before 1-month post-transplantation, and the risk of DSA occurrence, using Luminex based-methods. In total, 1,424 patients with a minimum of 1-month follow-up were evaluated between January 2007 and December 2018. During a median time of follow-up of 4.52 years, we observed 258 recipients who had at least one blood transfusion during the first month post-transplantation. At baseline, recipients in the transfused group were significant older, more sensitized against HLA class I and class II antibodies and had a higher 1-month serum creatinine. Cox proportional hazards regression analyses did not show any significant association between blood transfusion and the risk of de novo DSA occurrence (1.35 [0.86–2.11], p = 0.19), the risk of rejection (HR = 1.33 [0.94–1.89], p = 0.11), or the risk of graft loss (HR = 1.04 [0.73–1.50], p = 0.82). These data suggest then that blood transfusion may not be limited when required in the early phase of transplantation, and may not impact long-term outcomes.